The company received Establishment Inspection Report from the USFDA for its Indore facility indicating formal closure of the USFDA inspection conducted in July/August, 2015. Cipla Limited today announced that it has received Establishment Inspection Report (EIR) from the USFDA for its Indore facility indicating formal closure of the USFDA inspection conducted in July/August, 2015. Stock price: Cipla Ltd is currently trading at Rs. 594, up by Rs. 13.45 or 2.32% from its previous closing of Rs. 580.55 on the BSE. The scrip opened at Rs. 593.5 and has touched a high and low of Rs. 598.9 and Rs. 591 respectively. So far 795568 (NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs. 46688.44 crore. The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 704.75 on 29-Oct-2015 and a 52 week low of Rs. 458.25 on 25-May-2016. Last one week high and low of the scrip stood at Rs. 604 and Rs. 566.1 respectively. The promoters holding in the company stood at 36.77 % while Institutions and Non-Institutions held 33.9 % and 27.46 % respectively. If you want more information regarding the Market News & many other tips like Tradeindia Services , Intraday Tips , MCX Normal Calls , Indore Advisory Company , SEBI Registered Company , Share Market Services , NSE & BSE Market Tips , Free MCX Market Tips , MCX Premium Tips , Jewelers Contract , Commodity market tips , call @ +91-7415033556 or fill form http://tradeindiaresearch.com/freetrial.php
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
January 2017
Categories |